What Is Zepbound®?
Zepbound® is an FDA-approved, next-generation weight loss medication designed for long-term management of obesity and overweight. It contains tirzepatide, a powerful dual-action GLP-1 and GIP receptor agonist, which makes it one of the most effective treatments available today.
At our UChicago AdventHealth's Bariatric and Obesity Medicine Clinic in LaGrange —serving patients from Naperville, Oak Brook, Hinsdale, and surrounding western Chicago suburbs—our board-certified obesity medicine specialists prescribe Zepbound® as part of a personalized plan to help reduce appetite, improve fullness, and support healthy metabolic function.
Why Zepbound®?
Zepbound® works by:
- Reducing hunger signals
- Slowing digestion
- Improving insulin sensitivity
- Enhancing satiety and portion control
When combined with lifestyle changes, patients have seen 15–20% total body weight loss, often with better energy, fewer cravings, and improved health outcomes.
What Is Mounjaro®?
Mounjaro® also contains tirzepatide, but is currently FDA-approved only for the treatment of type 2 diabetes. However, due to its appetite-suppressing effects and metabolic benefits, many healthcare providers—including those at our UChicago AdventHealth-affiliated clinic—prescribe Mounjaro® off-label for weight loss when appropriate.
Zepbound® vs. Mounjaro®: What’s the Difference?
|
Feature |
Zepbound® |
Mounjaro® |
|
FDA Approval |
Weight Management |
Type 2 Diabetes |
|
Active Ingredient |
Tirzepatide |
Tirzepatide |
|
Mechanism |
Dual GLP-1 & GIP Agonist |
Dual GLP-1 & GIP Agonist |
|
Use Case |
Obesity / Overweight |
Blood Sugar Management & Off-label Weight Loss |
Both are highly effective in reducing body weight, but Zepbound® is specifically approved for chronic weight management, making it a preferred option when insurance allows.
How Tirzepatide Works
Tirzepatide mimics GLP-1 and GIP, two natural hormones that:
- Regulate blood sugar and insulin response
- Reduce appetite and slow gastric emptying
- Increase the feeling of fullness
- Support long-term weight loss and metabolic health
This dual-hormone approach makes tirzepatide-based medications like Zepbound® and Mounjaro® highly effective for patients struggling with weight loss resistance.
Real Results in Chicago’s Western Suburbs
Patients using tirzepatide at our clinic near Western Springs, Burr Ridge, and Downers Grove often report:
✅ Losing up to 15–20% of body weight
✅ Better control of cravings and portion sizes
✅ Improvements in blood pressure, cholesterol, and insulin resistance
Side Effects to Expect
While most people tolerate tirzepatide well, early side effects may include:
- Nausea
- Constipation or diarrhea
- Mild fatigue or abdominal discomfort
These typically resolve over time and are managed closely by our experienced team of obesity doctors.
Am I a Candidate?
You may qualify for Zepbound® or Mounjaro® if you:
✅ Have a BMI of 30+, or 27+ with weight-related conditions (e.g., diabetes, high blood pressure)
✅ Have not had success with diet and exercise alone
✅ Are ready to commit to long-term lifestyle changes with medical support
Start Tirzepatide Treatment at UChicago AdventHealth's Bariatric and Obesity Medicine Clinic in LaGrange
At our Chicago western suburbs clinic, we offer virtual and in-person care to help you determine whether Zepbound®, Mounjaro®, or another GLP-1/GIP option is right for you. Every plan is guided by board-certified obesity medicine physicians who specialize in evidence-based weight loss treatment.
🩺 Expert care
📦 No in-office visits required
💬 Local support—just a click away
Ready to begin your journey with tirzepatide?
Contact us today to book your initial consultation and explore options with Zepbound®, Mounjaro®, and more—personalized for you.
